Hyperfine, Inc. (HYPR)
0.761
-0.04
(-4.89%)
USD |
NASDAQ |
Oct 15, 14:56
Hyperfine Profit Margin (Quarterly) : -238.2% for June 30, 2026
Profit Margin (Quarterly) Chart
Historical Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -238.2% |
| March 31, 2026 | -220.9% |
| December 31, 2025 | -111.7% |
| September 30, 2025 | -320.6% |
| June 30, 2025 | -342.2% |
| March 31, 2025 | -440.7% |
| December 31, 2024 | -447.7% |
| September 30, 2024 | -283.4% |
| June 30, 2024 | -279.7% |
| March 31, 2024 | -298.9% |
| December 31, 2023 | -397.8% |
| September 30, 2023 | -461.7% |
| Date | Value |
|---|---|
| June 30, 2023 | -314.6% |
| March 31, 2023 | -461.5% |
| December 31, 2022 | -917.1% |
| September 30, 2022 | -560.9% |
| June 30, 2022 | -1.51K% |
| March 31, 2022 | -1.58K% |
| December 31, 2021 | -5.98K% |
| September 30, 2021 | -4.42K% |
| June 30, 2021 | -4.07K% |
| March 31, 2021 | -2.35K% |
| December 31, 2020 | -3.31K% |
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Profit Margin (Quarterly) Benchmarks
| Abbott Laboratories | 7.37% |
| AngioDynamics, Inc. | -8.77% |
| Alphatec Holdings, Inc. | -12.07% |
| AtriCure, Inc. | 5.83% |
| Baxter International, Inc. | 4.56% |
Profit Margin (Quarterly) Related Metrics
| Return on Equity | -100.1% |
| Return on Assets | -65.67% |
| Return on Invested Capital | -86.42% |
| Gross Profit Margin (Quarterly) | 50.72% |
| Operating Margin (Quarterly) | -216.9% |
| Return on Net Operating Assets | -214.8% |